News

Launch of Largest Canadian study on Dementia

To mark World Alzheimer’s Day (September 21, 2016), the Canadian Consortium on Neurodegeneration in Aging (CCNA) is launching its signature clinical study, the Comprehensive Assessment of Neurodegeneration and Dementia (COMPASS-ND). Over the next two years, the study will enroll 1600 participants, between the ages of 50 and 90 with memory problems from 30 sites across…

“Paving the way to Precision Medicine for people with dementia”

“The significance of vascular health to the public can’t be overstated: It may be the only modifiable degenerative condition leading to dementia.” Dr. Eric Smith Over the past 10 years, dementia researchers have established that vascular cognitive impairment (VCI) is common in the brains of older people, accounting for up to 33% of the risk…

Q&A at the starting line: The Comprehensive Assessment of Neurodegeneration and Dementia (COMPASS-ND) study

1) What does COMPASS-ND stand for? COMPASS-ND stands for: COMPrehensive ASSessment of Neurodegeneration and Dementia. What this means is we’re looking broadly at different types of dementia (including Alzheimer’s disease, Frontotemporal, Lewy Body, and Parkinson’s related dementia) and even potential pre-dementia conditions, like Mild Cognitive Impairment and Subjective Cognitive Decline. We’re taking this broad approach…